ArticleSurgical endoscopy2026
Expert panel perspectives on management of GERD post esophageal POEM: a national survey study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsGastroesophageal reflux disease (GERD) remains a major issue in the management of patients with achalasia after esophageal peroral endoscopic myotomy (E-POEM). This study investigated practice patterns surrounding empiric acid suppression, medication de-escalation, pH testing, and follow-up endoscopy of expert gastroenterologists managing these patients.
methodsAn online 17-item survey study was conducted in November 2024 with a response rate of 30/60. Expertise was determined by prior E-POEM publications and participation in the Delphi consensus on this topic and was validated by reported years of E-POEM experience and average number of E-POEMs performed annually.
results90% of responders performed E-POEM and 10% solely managed patients afterwards. 72% practiced in an academic institution and 45% performed more than 50 E-POEMs annually. There was no consensus on dose of acid suppression, but the most common regimen was a 40 mg omeprazole equivalent daily until follow-up. Responders had varied approaches to de-escalation, with 44% consistently performing pH testing. 48% performed endoscopic screening for Barrett's esophagus/cancer, and 83% of these continued at a regular interval indefinitely. 65% of responders reported taking procedural steps to minimize GERD after E-POEM, most often short myotomy (76%), and 24% a "tailored" approach using EndoFLIP.
conclusionsThe majority of experts reported taking measures during E-POEM to limit the risk of GERD. Despite GERD being an important consideration, experts remained almost evenly divided on the role of reflux testing in medication de-escalation and on the practice of endoscopic screening. Prospective studies informed by these expert insights would be especially valuable in determining whether pH testing and endoscopic screening for GERD complications improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.